Physician alerts to increase antidepressant adherence: Fax or fiction?

Archives of Internal Medicine

Volumn 166, Issue 5, 2006, Pages 498-504

  Bambauer, Kara Zivin ^a,b   Adams, Alyce S ^a,b   Zhang, Fang ^a,b   Minkoff, Neil ^a,b   Grande, Andrea ^a,b   Weisblatt, Rick ^a   Soumerai, Stephen B ^a,b   Ross Degnan, Dennis ^a,b  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; ISOCARBOXAZID; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PHENELZINE; SERTRALINE; TRANYLCYPROMINE; VENLAFAXINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; ANTIDEPRESSIVE AGENTS; CLINICAL PHARMACY INFORMATION SYSTEMS; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; UNITED STATES;

EID: 33644986986     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.5.498     Document Type: Article

References (50)

1. Goetzel RZ, Anderson DR, Whitmer RW, Ozminkowski RJ, Dunn RL, Wasserman J. The relationship between modifiable health risks and health care expenditures: an analysis of the multi-employer HERO health risk and cost database: the Health Enhancement Research Organization (HERO) Research Committee. J Occup Environ Med. 1998;40:843-854.
2. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff (Millwood). 1999;18:163-171.
3. Rice DP, Miller LS. The economic burden of affective disorders. Br J Psychiatry Suppl. 1995;(27):34-42.
4. Simon GE, Revicki D, Heiligenstein J, et al. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry. 2000;22:153-162.
5. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry. 2003;54:208-215.
6. Clinical Practice Guideline Number 5: Depression in Primary Care, 2: Treatment of Major Depression. Rockville, Md: Agency for Health Care Policy and Research, US Dept of Health and Human Services; 1993. AHCPR publication 93-0551.
7. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55:1128-1132.
8. DiMatteo MR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary. 1995;30:596-598.
9. Masand PS. Tolerability and adherence issues in antidepressant therapy. Clin Ther. 2003;25:2289-2304.
10. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, I: beyond lack of efficacy and adverse events. J Clin Psychiatry. 2001;62(suppl 22):30-33.
11. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196-201.
12. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67-74.
13. Kobak KA, Taylor L, Katzelnick DJ, Olson N, Clagnaz P, Henk HJ. Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence. J Clin Psychiatry. 2002;63:727-732.
14. Lin EH, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25:303-310.
15. Vergouwen AC, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2003;64:1415-1420.
16. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002;59:1518-1526.
17. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-2879.
18. Schulberg HC, Block MR, Madonia MJ, Rodriguez E, Scott CP, Lave J. Applicability of clinical pharmacotherapy guidelines for major depression in primary care settings. Arch Fam Med. 1995;4:106-112.
19. Pearson SA, Ross-Degnan D, Payson A, Soumerai SB. Changing medication use in managed care: a critical review of the available evidence. Am J Manag Care. 2003;9:715-731.
20. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity. N Engl J Med. 1987;317:550-556.
21. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:650-655.
22. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:1072-1077.
23. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health. 1981;71:38-46.
24. Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB. Shifting physician prescribing to a preferred histamine-2-receptor antagonist: effects of a multifactorial intervention in a mixed-model health maintenance organization. Med Care. 1998;36:321-332.
25. Cook TD, Campbell DT. Quasi-experimentation: Design and Analysis Issues for Field Settings. Boston, Mass: Houghton Mifflin Co; 1979.
26. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289:3145-3151.
27. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-1161.
28. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2003;18:967-976.
29. Tierney WM, Overhage JM, Murray MD, et al. Can computer-generated evidencebased care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? a randomized, controlled trial. Health Serv Res. 2005;40:477-498.
30. Majumdar SR, Soumerai SB. Why most interventions to improve physician prescribing do not seem to work. CMAJ. 2003;169:30-31.
31. Cabana MD, Rushton JL, Rush AJ. Implementing practice guidelines for depression: applying a new framework to an old problem. Gen Hosp Psychiatry. 2002;24:35-42.
32. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288:2880-2883.
33. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-1031.
34. Aubert RE, Fulop G, Xia F, Thiel M, Maldonato D, Woo C. Evaluation of a depression health management program to improve outcomes in first or recurrent episode depression. Am J Manag Care. 2003;9:374-380.
35. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403-1409.
36. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 2002;180:104-109.
37. Dietrich AJ, Oxman TE, Burns MR, Winchell CW, Chin T. Application of a depression management office system in community practice: a demonstration. J Am Board Fam Pract. 2003;16:107-114.
38. Bieszk N, Patel R, Heaberlin A, Wlasuk K, Zarowitz B. Detection of medication nonadherence through review of pharmacy claims data. Am J Health Syst Pharm. 2003;60:360-366.
39. Adler DA, Bungay KM, Wilson IB, et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004;26:199-209.
40. Simon GE, Katon WJ, VonKorff M, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry. 2001;158:1638-1644.
41. Rollman BL, Hanusa BH, Lowe HJ, Gilbert T, Kapoor WN, Schulberg HC. A randomized trial using computerized decision support to improve treatment of major depression in primary care. J Gen Intern Med. 2002;17:493-503.
42. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550-554.
43. Hoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C. Impact of an antidepressant management program on medication adherence. Am J Manag Care. 2003;9:70-80.
44. National Center for Quality Assurance. HEDIS 3.0: Effectiveness of Care: Anti-Depressant Medical Management. Washington, DC; National Center for Quality Assurance; 1997.
45. Bambauer KZ, Soumerai SB, Adams AS, Mah C, Zhang F, McLaughlin TJ. Does antidepressant adherence have an effect on glycemic control among diabetic antidepressant users? Int J Psychiatry Med. 2004;34:291-304.
46. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
47. Chan KA, Platt R. Harvard Pilgrim Health Care/Harvard Vanguard Medical Associates. In: Strom BL, ed. Pharmacoepidemiology. 3rd ed. New York, NY: John Wiley & Sons Inc; 2000:277-287.
48. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001;52:805-811.
49. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
50. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-511.